DTE Q1 2026 Earnings EPS Misses Estimates Amid Regulatory and Operational Headwinds CTNT Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Management Amidst Revenue Uncertainty THFF Q1 2026 Earnings Modest EPS Beat Fails to Lift Shares Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Sangoma Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear